USPTO 2015–2025 USPTO PatentsView US Corporation

Antecip Bioventures II LLC

USPTO PatentsView assignee record - 248 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Antecip ranks #1,655 of 49,997 tracked US assignees by granted-patent volume, with 248 patents across 8 technology areas.

#1,655
of 49,997 US assignees by volume
Top 14%
by Innovation Score (49.7/100)
22.9
avg claims per patent
-24%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1655 · US Corporation #1,655 · 248 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-MID 248 grants
  • TOP-DECILE #1,655/49,997
  • PHOTO-FINISH Activision Publishing
  • CPC-NARROW A61K · 8 areas
  • INNOV-PAR 49.7/100
  • CLAIMS-DENSE 22.9 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DOWN -24% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Activision Publishing, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Antecip

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Antecip's Innovation Score is 49.7/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Antecip's grants concentrate

Antecip Bioventures II LLC is a focused PatentsView assignee: 8 CPC subclasses with 99.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2018 (45 grants) versus a trough of 10 in 2024. By volume, Antecip sits between Arkema Inc. and Magpul Industries Corp..

Antecip's three-year grant acceleration

From 2019–2021 to 2022–2024, Antecip Bioventures II LLC moved from 58 to 60 grants (1.03x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,094. See the growth leaderboard.

Who files at Antecip's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Antecip holds 248 patents at rank #1,653, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Antecip

By rank, the assignees closest to #1,653 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Antecip's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Antecip, neither rank-band nor same-CPC leaders (those blocks stay above).

Antecip's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

01020304050 20152016201720182019202020212022202320242025 10
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Antecip Bioventures II LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 12 4.8%
2016 30 12.1%
2017 33 13.3%
2018 45 18.1%
2019 15 6.0%
2020 15 6.0%
2021 28 11.3%
2022 32 12.9%
2023 18 7.3%
2024 10 4.0%
2025partial year 10 4.0%

Where it ranks

Overall rank by patents

#1,655

of 49,997 tracked assignees

Innovation Score

49.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Antecip Bioventures II LLC's patent record in context - here's where to go next.

  • Antecip Bioventures II LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 99.2% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #1,655 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Antecip Bioventures II LLC against Arkema Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 49.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.